期刊文献+

重症肌无力的发病机制及临床治疗研究新进展 被引量:1

New Progress in Pathogenesis and Clinical Treatment of Myasthenia Gravis
暂未订购
导出
摘要 重症肌无力是一种神经肌肉接头传递功能障碍的获得性自身免疫性疾病,80%以上的重症肌无力患者存在胸腺异常。主要临床表现为疲劳后加重的肌无力症状,多数患者于晨起或下午发病,晨轻暮重,活动后症状加重。可伴发吞咽困难、说话不清、饮水呛咳、呼吸困难等,大大降低了患者的生存质量。本文对重症肌无力的发病机制进行分析,并探讨了对重症肌无力的临床治疗方法,目的在于全面而真实地了解不同疗法的效果及副作用,通过真实的综合结论为重症肌无力的治疗提供依据。 Myasthenia gravis is an autoimmune disease that affects neuromuscular junction,and over 80% of myasthenia gravis patients have thymic abnormalities.Main clinical manifestation is muscle weakness symptoms worsening after fatigue.Most patients develop symptoms in the morning or afternoon,being mild in the morning and severe in the evening,and symptoms worsen after physical activity.It can be accompanied by swallowing difficulty,unclear speech,coughing when drinking,and breathing difficulty,which reduces life quality of patients greatly.The paper analysed pathogenesis of myasthenia gravis and explored clinical treatment methods of myasthenia gravis,to understand effect and side effect of different therapies comprehensively and truthfully,and provide basis for treatment of myasthenia gravis based on authentic comprehensive conclusions.
作者 曹文宇 樊兴娟 CAO Wenyu;FAN Xingjuan(Nantong University Affiliated Hospital,Nantong,Jiangsu 226001)
出处 《智慧健康》 2024年第3期33-36,共4页 Smart Healthcare
关键词 重症肌无力 发病机制 治疗 进展 综述 Myasthenia gravis Pathogenesis Treatment Progress Summary
  • 相关文献

参考文献17

二级参考文献63

共引文献443

同被引文献21

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部